<DOC>
	<DOCNO>NCT00500812</DOCNO>
	<brief_summary>This trial multi-center , open-label , dose-escalation study design evaluate safety , tolerability pharmacokinetics Cethrin two type spinal cord injury patient : complete cervical injury complete thoracic injury . Dose level 0.3 mg - 9 mg Cethrin administer .</brief_summary>
	<brief_title>A Safety Study Cethrin ( BA-210 ) Treatment Acute Thoracic Cervical Spinal Cord Injuries</brief_title>
	<detailed_description />
	<mesh_term>Wounds Injuries</mesh_term>
	<mesh_term>Spinal Cord Injuries</mesh_term>
	<criteria>Patients enrol study meet follow criterion : Informed Consent Form sign patient patient 's legal representative . Male female , aged 1670 year , inclusive . For Group 1 , patient acute thoracic ( T2T12 ) spinal cord injury ; Group 2 , patient acute cervical ( C4T1 ) spinal cord injury . The site surgery able accommodate minimum volume 2 mL fibrin sealant . Scheduled undergo spinal decompression surgery interventional spinal surgery ( e.g. , fixation ) within 7 day injury . ASIA Impairment Scale grade A ( complete , motor sensory function present sacral segment ) assess within 12 hour surgery . Able communicate effectively obtain informed consent ensure neurological examination . Patients enrol study meet one follow criterion : Use experimental drug , participation clinical trial , within 30 day prior surgery . History adverse reaction fibrin sealant . History hypersensitivity bovine product . Any medical condition may interfere ASIA assessment . Clinically significant neurological , cardiac , respiratory , hepatic , renal disease malignancy . Hemophilia bleed abnormality define : Platelet level low 100 X 109/L Activated partial thromboplastin time international normalize ratio high upper limit normal Baseline hematocrit lower 0.25 Gunshot wound present injury , evidence transect injury spinal cord ( e.g. , stab wound ) . Cognitive impairment may preclude accurate neurological assessment ( e.g . traumatic head injury GCS le equal 14 ) . Ankylosing Spondylitis . Diabetes mellitus require insulin therapy . Known immunodeficiency , include Acquired Immune Deficiency Syndrome use immunosuppressive cancer chemotherapeutic drug . Pregnancy breastfeed study . A serum pregnancy test perform Screening female patient childbearing potential . In addition , patient consider likely pregnant may exclude th Investigator 's discretion . Any condition situation likely cause patient unable unwilling participate study procedure participate schedule study assessment , include follow Month 6 . Any condition likely result patient 's death within next 6 Months . Any condition , opinion Investigator , would preclude patient 's participation study . Previous participation study . Use intravenous heparin previous 48 hour , thrombolytic and/or aspirin contain product previous 10 day . Nontraumatic cause spinal cord injury ( e.g . transverse myelitis , acute disc herniation , etcâ€¦ ) .</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>biologic drug</keyword>
	<keyword>transport sequence</keyword>
	<keyword>rho</keyword>
	<keyword>spinal cord injury</keyword>
	<keyword>paralysis</keyword>
	<keyword>paraplegia</keyword>
	<keyword>tetraplegia</keyword>
	<keyword>quadraplegia</keyword>
	<keyword>trauma</keyword>
	<keyword>nervous system</keyword>
	<keyword>fibrin sealant</keyword>
	<keyword>neurosurgery</keyword>
</DOC>